Biotechs Bounce From Support Levels Despite Mixed Earnings Reports…Update 5/3- Testing 2018 Lows
5/3 Testing February bottom and 200 MA of ~$100 on IBB and ~$85 on XBI. Red screen day. 2PM EDT Dow near flat line. Need to look for major gap up. Another potential negative on the horizon: "Bold Action on Drug Pricing" by Sect'y HHS. 5/2 Biotech Stocks Are About To Test 2018 Lows: It is all...
2018 Biotech Sector Watch on Earnings #2: ABBV, ALXN, BMY…Updates VRTX
Update 4/30... Vertex Pharmaceuticals (VRTX) Beat Consensus by 4% Financial Results: CF Revenues rose 33% Q'18 o Q'17 from $481M to $638M; GAAP net income down 15% ,$210M from $241M. Two Phase 3 triple combination clinical development programs are underway : VX-559 and VX-441 best for 2020...
2018 Biotech Sector Watch on Earnings #1: AMGN,BIIB…Updates
Update 4/25: Investors May See Value in Large Cap Biotech Amgen (AMGN) up 1.68%. Biogen (BIIB) holds Tuesday lows of $262 Up 2.78% today. IBB flat at $103.26 More earnings tomorrow but it is all about technicals holding the recent bottom. ========== Biotech Sector Watch on 2018 Earnings...
Biotech and Pharma Stocks Await Q1 Earnings But Gene Editing Stocks Sell-Off
Speculative Biotech Stocks Sell-Off in Profit Taking: Gene Editing Biotech stocks held current levels but small caps and speculative stocks sold off with the XBI down 1%. Most large caps were in the green with an upgrade from Goldman Sachs helping Merck (MRK) up 2.4% with a bullish story on...
Biotechs Stalled and Get No Help From Monday’s Market Moves…Updates
Updates: 4/19/18 GWPH hits $143 new high, then sold off holding $134 level, after big move from $105 on cannabis drug for severe epilepsy FDA Advisory go ahead. Biotechs broadly in the red except CRSP up 6.4% and NVCR up 5%. AstraZeneca (AZN) gained US approval for 1st line use of lung cancer...